Necitumumab Biosimilar (ERBB1 / EGFR / HER1 Reference Antibody)
Necitumumab (anti-EGFR) is an epidermal growth factor receptor (EGFR) antagonist that can be used in combination with gemcitabine and cisplatin for the first-line treatment of patients with metastatic squamous non-small cell lung cancer.
Product Specifications
Target
Necitumumab Biosimilar (Anti-ERBB1 / EGFR / HER1 Reference Antibody)
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology
Purity
>98%
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
